Sulfonyl-γ-AAs act as β-turn templates, robustly inducing β-sheet conformation in macrocyclic peptides
Background
Designing synthetic β-sheet mimics remains a significant challenge despite their critical role in protein secondary structures and diverse biological functions. These structures are essential for protein-protein interactions and are implicated in various diseases, including Alzheimer's disease where amyloid-beta (Aβ) aggregation involves the formation of toxic β-sheet fibrils. Current approaches struggle with sequence-dependent folding, limiting the development of stable, functional mimetics. A robust method for inducing predictable β-turn structures could unlock new avenues for therapeutic development and advanced biomaterials by enabling the creation of stable, antiparallel β-sheet architectures.
Study Design
Researchers synthesized novel sulfonyl-γ-AAs (γ-substituted-N-sulfonyl-N-aminoethyl amino acids) and incorporated them into macrocyclic peptides. They performed single-crystal X-ray diffraction on sulfonyl-γ-AAs B1 and a macrocyclic peptide BS-1 containing these residues to elucidate their precise structural conformation. To further characterize the induced secondary structures, circular dichroism (CD) spectroscopy was applied to peptides BS-6 through BS-9. Additionally, 2D-NMR studies were conducted to confirm the folded solution structures and their consistency with the crystal structures, providing comprehensive insights into the β-sheet induction mechanism.
Results
Sulfonyl-γ-AAs were confirmed as effective artificial β-turn inducers, driving stable β-sheet conformations in macrocyclic peptides. Single-crystal X-ray diffraction of sulfonyl-γ-AAs B1 and macrocyclic peptide BS-1 revealed that the sulfonyl-γ-AAs adopt a β-turn-like conformation. This conformation is stabilized by both intramolecular hydrogen bonding and the intrinsic curvature of the sulfonamido moiety, which collectively facilitate the formation of a folded β-sheet structure with defined amino acid residues. This work represents the first crystallographic validation of a polyalanine β-sheet structure enforced by a β-turn mimic. Moreover, circular dichroism (CD) spectroscopy of BS-6 to BS-9 displayed characteristic minima between 208-214 nm, consistent with robust β-sheet signatures. 2D-NMR studies further corroborated these findings, revealing well-folded solution structures that were consistent with the X-ray crystal structures.
These results establish sulfonyl-γ-AAs as a versatile class of β-turn templates that effectively drive β-sheet formation, enabling the creation of novel macrocyclic antiparallel β-sheet mimics.
Key Findings
- Sulfonyl-γ-AAs successfully induce stable β-sheet conformations in macrocyclic peptides.
- X-ray diffraction confirmed sulfonyl-γ-AAs adopt a β-turn-like conformation, stabilized by intramolecular hydrogen bonding.
- Circular dichroism (CD) spectroscopy showed characteristic minima between 208-214 nm, indicative of β-sheet structures.
- 2D-NMR studies validated well-folded solution structures consistent with crystal structures.
- First crystallographic validation of a polyalanine β-sheet structure enforced by a β-turn mimic.
Why It Matters
This breakthrough provides a powerful new tool for designing stable β-sheet mimetics, which are crucial for developing therapeutics targeting protein misfolding diseases like Alzheimer's disease and for advanced biomaterials. By offering a reliable method to induce specific β-sheet structures, this research significantly advances the field of peptide engineering. Peptide designers can now leverage sulfonyl-γ-AAs to create macrocyclic peptides with predictable and stable antiparallel β-sheet conformations, potentially leading to novel inhibitors of amyloid aggregation or scaffolds for drug delivery. This work moves us closer to rationally designing peptides with tailored biological functions, opening doors for new therapeutic strategies and functional biomaterials that mimic natural protein structures more effectively.
sulfonyl-gamma-aas
beta-sheet
beta-turn
macrocyclic peptides
protein folding
peptide design